// App-Quantinova.ai

e21016 : Risk of venous thromboembolism in cancer patients treated with cisplatin: A systematic review and meta-analysis.

Researchers

Presenter

  • Sonia Maria Seng

Principal Investigators

  • Ziyue Liu

  • Sophia Chiu

  • Tracey Proverbs-Singh

  • Guru Sonpavde

  • Toni K. Choueiri

  • Che-Kai Tsao

  • Menggang Yu

  • Noah M. Hahn

  • William K. Oh

  • Matt D. Galsky

Medical Centers

  • Division of Medical Oncology, Texas Oncology Deke-Slayton Cancer Center, Baylor College of Medicine, Houston, TX

  • Southcoast Centers for Cancer Care, Fairhaven, MA

  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

  • Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN

  • Mount Sinai School of Medicine, New York, NY

  • Division of Biostatistics, Indiana University, Indianapolis, IN

  • Indiana University School of Medicine and Melvin and Bren Simon Cancer Center, Indianapolis, IN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved